Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
Edward William JohnstonArash LatifoltojarHarbir Singh SidhuNavin RamachandranMagdalena SokolskaAlan BainbridgeCaroline MooreHashim Uddin AhmedNikolaos DikaiosPublished in: European radiology (2018)
• A whole-body MRI protocol comprising unenhanced mDixon and diffusion-weighted imaging provides high levels of diagnostic accuracy for the primary staging of intermediate- and high-risk prostate cancer. • The diagnostic accuracy of whole-body MRI is much higher than that of bone scintigraphy, as currently recommended for clinical use. • Staging using WB-MRI, rather than bone scintigraphy, could result in better patient stratification and treatment delivery than is currently provided to patients worldwide.
Keyphrases
- diffusion weighted imaging
- contrast enhanced
- prostate cancer
- newly diagnosed
- magnetic resonance imaging
- pet ct
- lymph node
- radical prostatectomy
- end stage renal disease
- computed tomography
- squamous cell carcinoma
- magnetic resonance
- randomized controlled trial
- bone mineral density
- small cell lung cancer
- chronic kidney disease
- ejection fraction
- soft tissue
- prognostic factors
- case report
- peritoneal dialysis
- combination therapy
- radiation therapy
- rectal cancer